Sleep Apnea News & Updates
FDA Approves Zepbound for Obstructive Sleep Apnea
- Sleep Apnea May Be Even More Dangerous Than We Thought
October 7, 2024 — More research is finding this common and vastly underdiagnosed sleep disorder may significantly increase the risk of cancer.
- New Drug Offers Hope for CPAP-Free Nights for Sleep Apnea
May 30, 2024 — The pill, which is still in clinical trials, has shown the ability to significantly improve sleep apnea in patients without using a CPAP machine.
- Eli Lilly to Ask FDA to Approve Weight Loss Drug for Sleep Apnea
April 17, 2024 — Preliminary clinical trial results showed the obesity drug tirzepatide was highly effective at treating obstructive sleep apnea, according to information sent to investors of the pharmaceutical company Eli Lilly.
- Sleep Apnea Linked to Brain Aging, Dementia, and Stroke
May 11, 2023 — The findings were not conclusive enough to allow researchers to say that sleep apnea causes cognitive decline or stroke, but are sound enough to point scientists toward further exploration.
- FDA Recalls Some Philips Sleep Apnea Devices
April 10, 2023 — Some sleep apnea machines made by Philips Respironics are being recalled for a second time, the FDA announced.
- CPAP Recall Drags on After More Than a Year
October 26, 2022 — The recall of millions of breathing devices that help people sleep because of a potential hazard has yet to be resolved. The Dutch company Philips said then it could repair or replace the units within a year. Instead, the recall grew to more than 5 million devices around the globe, and the problem could persist into next year.
